SCHEMBL10241749

SCHEMBL10241749

O=C(Nc1cc(-c2cccc(NCC3CCOCC3)c2)c(Cl)cn1)[C@H]1CNCCOC1

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CDK9 P50750 19/20 0.58
CCNT1 O60563 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10242935 0.94 CDK9 (0.61) CDK9CCNT1
SCHEMBL10241728 0.94 CDK9 (0.61) CDK9CCNT1
SCHEMBL10242727 0.92 CDK9 (0.62) CDK9CCNT1
SCHEMBL1441021 0.91 CDK9 (0.68) CDK9CCNT1
SCHEMBL1439270 0.91 CDK9 (0.68) CDK9CCNT1
SCHEMBL1439276 0.91 CDK9 (0.68) CDK9CCNT1
SCHEMBL10241826 0.91 CDK9 (0.62) CDK9CCNT1
SCHEMBL10241789 0.91 CDK9 (0.65) CDK9CCNT1
SCHEMBL10241773 0.91 CDK9 (0.48) CDK9CCNT1
SCHEMBL10241825 0.90 CDK9 (0.65) CDK9CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120157433-A1 Heteroaryl Compounds as Kinase Inhibitors PFISTER KEITH B (US) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157433-A1 Heteroaryl Compounds as Kinase Inhibitors CDK2, CDK1, CDK6 CDK9 6/4885CCNT1 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.